Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor

Vikas Bhat, Max B. Olenick, Brett J. Schuchardt, David C. Mikles, Caleb B. McDonald, Amjad Farooq

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

B-cell lymphoma extra-large protein (BclXL) serves as an apoptotic repressor by virtue of its ability to recognize and bind to BH3 domains found within a diverse array of proapoptotic regulators. Herein, we investigate the molecular basis of the specificity of the binding of proapoptotic BH3 ligands to BclXL. Our data reveal that while the BH3 ligands harboring the LXXX[A/S]D and [R/Q]XLXXXGD motif bind to BclXL with high affinity in the submicromolar range, those with the LXXXGD motif afford weak interactions. This suggests that the presence of a glycine at the fourth position (G+4) - relative to the N-terminal leucine (L0) within the LXXXGD motif - mitigates binding, unless the LXXXGD motif also contains arginine/glutamine at the -2 position. Of particular note is the observation that the residues at the +4 and -2 positions within the LXXX[A/S]D and [R/Q]XLXXXGD motifs appear to be energetically coupled - replacement of either [A/S]+4 or [R/Q]-2 with other residues has little bearing on the binding affinity of BH3 ligands harboring one of these motifs. Collectively, our study lends new molecular insights into understanding the binding specificity of BH3 ligands to BclXL with important consequences on the design of novel anticancer drugs.

Original languageEnglish
Pages (from-to)573-582
Number of pages10
JournalBiopolymers
Volume101
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Repressor Proteins
B-Cell Lymphoma
Ligands
Proteins
Bearings (structural)
Arginine
Glutamine
Leucine
Glycine
Amino acids
Cells
Pharmaceutical Preparations

Keywords

  • BclXL-BH3 recognition
  • binding specificity
  • energetic coupling
  • salt dependence

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Biomaterials
  • Organic Chemistry

Cite this

Bhat, V., Olenick, M. B., Schuchardt, B. J., Mikles, D. C., McDonald, C. B., & Farooq, A. (2014). Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor. Biopolymers, 101(6), 573-582. https://doi.org/10.1002/bip.22419

Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor. / Bhat, Vikas; Olenick, Max B.; Schuchardt, Brett J.; Mikles, David C.; McDonald, Caleb B.; Farooq, Amjad.

In: Biopolymers, Vol. 101, No. 6, 01.01.2014, p. 573-582.

Research output: Contribution to journalArticle

Bhat, V, Olenick, MB, Schuchardt, BJ, Mikles, DC, McDonald, CB & Farooq, A 2014, 'Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor', Biopolymers, vol. 101, no. 6, pp. 573-582. https://doi.org/10.1002/bip.22419
Bhat, Vikas ; Olenick, Max B. ; Schuchardt, Brett J. ; Mikles, David C. ; McDonald, Caleb B. ; Farooq, Amjad. / Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor. In: Biopolymers. 2014 ; Vol. 101, No. 6. pp. 573-582.
@article{8c26ae6cb5fc4cb7a07d4e73f989128c,
title = "Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor",
abstract = "B-cell lymphoma extra-large protein (BclXL) serves as an apoptotic repressor by virtue of its ability to recognize and bind to BH3 domains found within a diverse array of proapoptotic regulators. Herein, we investigate the molecular basis of the specificity of the binding of proapoptotic BH3 ligands to BclXL. Our data reveal that while the BH3 ligands harboring the LXXX[A/S]D and [R/Q]XLXXXGD motif bind to BclXL with high affinity in the submicromolar range, those with the LXXXGD motif afford weak interactions. This suggests that the presence of a glycine at the fourth position (G+4) - relative to the N-terminal leucine (L0) within the LXXXGD motif - mitigates binding, unless the LXXXGD motif also contains arginine/glutamine at the -2 position. Of particular note is the observation that the residues at the +4 and -2 positions within the LXXX[A/S]D and [R/Q]XLXXXGD motifs appear to be energetically coupled - replacement of either [A/S]+4 or [R/Q]-2 with other residues has little bearing on the binding affinity of BH3 ligands harboring one of these motifs. Collectively, our study lends new molecular insights into understanding the binding specificity of BH3 ligands to BclXL with important consequences on the design of novel anticancer drugs.",
keywords = "BclXL-BH3 recognition, binding specificity, energetic coupling, salt dependence",
author = "Vikas Bhat and Olenick, {Max B.} and Schuchardt, {Brett J.} and Mikles, {David C.} and McDonald, {Caleb B.} and Amjad Farooq",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/bip.22419",
language = "English",
volume = "101",
pages = "573--582",
journal = "Biopolymers - Peptide Science Section",
issn = "0006-3525",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor

AU - Bhat, Vikas

AU - Olenick, Max B.

AU - Schuchardt, Brett J.

AU - Mikles, David C.

AU - McDonald, Caleb B.

AU - Farooq, Amjad

PY - 2014/1/1

Y1 - 2014/1/1

N2 - B-cell lymphoma extra-large protein (BclXL) serves as an apoptotic repressor by virtue of its ability to recognize and bind to BH3 domains found within a diverse array of proapoptotic regulators. Herein, we investigate the molecular basis of the specificity of the binding of proapoptotic BH3 ligands to BclXL. Our data reveal that while the BH3 ligands harboring the LXXX[A/S]D and [R/Q]XLXXXGD motif bind to BclXL with high affinity in the submicromolar range, those with the LXXXGD motif afford weak interactions. This suggests that the presence of a glycine at the fourth position (G+4) - relative to the N-terminal leucine (L0) within the LXXXGD motif - mitigates binding, unless the LXXXGD motif also contains arginine/glutamine at the -2 position. Of particular note is the observation that the residues at the +4 and -2 positions within the LXXX[A/S]D and [R/Q]XLXXXGD motifs appear to be energetically coupled - replacement of either [A/S]+4 or [R/Q]-2 with other residues has little bearing on the binding affinity of BH3 ligands harboring one of these motifs. Collectively, our study lends new molecular insights into understanding the binding specificity of BH3 ligands to BclXL with important consequences on the design of novel anticancer drugs.

AB - B-cell lymphoma extra-large protein (BclXL) serves as an apoptotic repressor by virtue of its ability to recognize and bind to BH3 domains found within a diverse array of proapoptotic regulators. Herein, we investigate the molecular basis of the specificity of the binding of proapoptotic BH3 ligands to BclXL. Our data reveal that while the BH3 ligands harboring the LXXX[A/S]D and [R/Q]XLXXXGD motif bind to BclXL with high affinity in the submicromolar range, those with the LXXXGD motif afford weak interactions. This suggests that the presence of a glycine at the fourth position (G+4) - relative to the N-terminal leucine (L0) within the LXXXGD motif - mitigates binding, unless the LXXXGD motif also contains arginine/glutamine at the -2 position. Of particular note is the observation that the residues at the +4 and -2 positions within the LXXX[A/S]D and [R/Q]XLXXXGD motifs appear to be energetically coupled - replacement of either [A/S]+4 or [R/Q]-2 with other residues has little bearing on the binding affinity of BH3 ligands harboring one of these motifs. Collectively, our study lends new molecular insights into understanding the binding specificity of BH3 ligands to BclXL with important consequences on the design of novel anticancer drugs.

KW - BclXL-BH3 recognition

KW - binding specificity

KW - energetic coupling

KW - salt dependence

UR - http://www.scopus.com/inward/record.url?scp=84897093524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897093524&partnerID=8YFLogxK

U2 - 10.1002/bip.22419

DO - 10.1002/bip.22419

M3 - Article

C2 - 24114183

AN - SCOPUS:84897093524

VL - 101

SP - 573

EP - 582

JO - Biopolymers - Peptide Science Section

JF - Biopolymers - Peptide Science Section

SN - 0006-3525

IS - 6

ER -